Ochromycinone Uses, Dosage, Side Effects and more

Ochromycinone is under investigation in clinical trial NCT01047943 (STA-21 Topical Efficacy on Psoriasis).

Attribute	Details
Trade Name	Ochromycinone
Generic	Ochromycinone
Ochromycinone Other Names	(+)-ochromycinone, (3s)-3.beta.-methyl-8-hydroxy-1,2,3,4,7,12-hexahydrobenzo(a)anthracene-1,7,12-trione, Benz(a)anthracene-1,7,12(2h)-trione, 3,4-dihydro-8-hydroxy-3-methyl-, (s)-
Type
Formula	C19H14O4
Weight	Average: 306.317 Monoisotopic: 306.089208931
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph